3692:HKG
Hansoh Pharmaceutical Group Company Ltd
HK$34.14
0.00%
(0.00) 1D
Oct 2, 4:08:07 PM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3692...
Mkt. cap
206.98B
Avg. vol.
11.34M
Volume
0.00
Dividend
1.42%
Quarterly dividend
HK$0.12
Ex-dividend date
Sep 22, 2026
P/E ratio
26.42
52-wk high
HK$44.22
52-wk low
HK$28.06
EPS
HK$1.29
No. of employees
10K
Mkt. cap
206.98B
Avg. vol.
11.34M
Volume
0.00
Dividend
1.42%
Quarterly dividend
HK$0.12
Ex-dividend date
Sep 22, 2026
P/E ratio
26.42
52-wk high
HK$44.22
52-wk low
HK$28.06
EPS
HK$1.29
No. of employees
10K
News stories
From web sources and news partners
AD HOC NEWS
·
12 hours ago
Hansoh Pharma stock fell 3.29 percent on October 2 as obesity data arrived
Profile
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
About Hansoh Pharmaceutical Group Company Ltd